Table 2 The incidence of all-cause mortality, major cardiovascular adverse events, recurrent myocardial infarction, stent thrombosis, short-term bleeding events, revascularization, and retransfusioncalculated by the Egger’s method

All-cause mortality

Slope

6.7465

1.3173

5.12

0.023

3.8763

9.6167

Bias

 − 4.037

1.3441

 − 3.07

0.169

 − 6.9012

 − 1.1734

Major cardiovascular adverse events

Slope

6.5584

1.4123

7.30

0.000

1.9903

3.8294

Bias

1.0227

1.3917

2.42

0.134

0.1456

2.4913

Recurrent myocardial infarction

Slope

4.7574

1.6265

2.92

0.019

0.6229

8.4368

Bias

 − 1.6139

1.8549

 − 0.87

0.456

 − 6.2366

2.5831

Stent thrombosis in 30 days

Slope

3.1175

0.3462

0.23

0.834

 − 19.1951

22.1624

Bias

1.0227

0.4223

2.42

0.339

 − 16.8959

18.4912

Subacute stent thrombosis

Slope

8.2450

5.2901

1.56

0.363

 − 58.9723

75.4624

Bias

 − 5.1163

4.2493

 − 1.20

0.441

 − 59.1098

48.8771

Acute stent thrombosis

Slope

4.5230

7.3765

0.61

0.602

 − 27.2157

36.2618

Bias

 − 1.5006

5.0404

 − 0.30

0.794

 − 23.1880

20.1867

Short-term bleeding events

Slope

3.3284

0.7321

5.43

0.000

1.1564

4.4187

Bias

0.2967

0.8822

0.38

0.819

 − 1.5423

2.3893

Revascularization

Slope

0.2545

4.0988

0.07

0.694

 − 12.7673

13.3211

Bias

2.3470

4.0307

0.61

0.747

 − 10.3813

15.2735

Retransfusion

Slope

7.5548

2.9110

1.67

0.015

3.1010

12.0086

Bias

 − 4.5410

2.7337

 − 2.86

0.062

 − 9.6001

0.5185